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ABSTRACT
Objective: A systematic review of the association of
predialysis chronic kidney disease (CKD) with the
incidence of acute, community-acquired infections.
Design: We searched the MEDLINE, EMBASE and
Cochrane databases (inception to 16 January 2014) for
studies analysing the association of predialysis kidney
disease with the incidence of acute, community-
acquired urinary tract infection (UTI), lower respiratory
tract or central nervous system infections or sepsis.
Studies were required to include at least 30
participants with and without kidney disease.
Setting and participants: Community-based
populations of adults in high-income countries.
Outcome measures: Acute, community-acquired
UTI, lower respiratory tract or central nervous system
infections or sepsis.
Results: We identified 14 eligible studies. Estimates
from two studies lacked 95% CIs and SEs. The
remaining 12 studies yielded 17 independent effect
estimates. Only three studies included infections
managed in the community. Quality assessment
revealed that probable misclassification of kidney
disease status and poor adjustment for confounding
were common. There was evidence from a few large
high-quality studies of a graded association between
predialysis CKD stage and hospitalisation for infection.
One study found an interaction with age, with a
declining effect of CKD on infection risk as age
increased. There was evidence of between-studies
heterogeneity (I2=96.5%, p<0.001) which persisted in
subgroup analysis, and thus meta-analysis was not
performed.
Conclusions: Predialysis kidney disease appears to be
associated with increased risk of severe infection.
Whether predialysis kidney disease increases the
susceptibility to infections and whether age modifies
this association remains unclear.
INTRODUCTION
Chronic kidney disease (CKD) is common,
and its prevalence is increasing.1 Infection is
a major cause of mortality in end-stage renal
disease (ESRD) and hospitalisation at all
stages of CKD. The second commonest cause
of death among patients with ESRD in the
USA is septicaemia, and patients with ESRD
are at increased risk of death from infection
compared to the general population.2–4
Patients with ESRD and predialysis CKD in
the USA are at higher risk of hospitalisation
for infection than the general population.2 5 6
Predialysis CKD has been found to increase
mortality among patients hospitalised with
infections.7
Increased mortality and hospitalisation
from infection could be driven by increased
severity of infection, that is, once an infection
is present, the course of the associated illness
is more severe, or increased incidence, that is,
CKD may make people more susceptible to
develop an infection. Patients with CKD
display impaired host immunity: reduced vac-
cination responsiveness is observed at all
stages of CKD.8
Among patients with ESRD, aspects of dialy-
sis, such as vascular and peritoneal access for
dialysis, may be a risk factor for infection inci-
dence and severity. However, this does not tell
the whole story, and only 23% of infection-
related hospitalisations among patients
undergoing haemodialysis in the USA were
identiﬁed as related to vascular access in the
Strengths and limitations of this study
▪ This study used a sensitive search strategy, with
a broad definition of kidney disease, for a thor-
ough and inclusive search.
▪ Study quality was assessed using a tool adapted
to observational studies, providing a transparent
assessment of the risk of a range of biases for
each study.
▪ Between-study heterogeneity and the low quality
of many of the studies limit the interpretation of
results of the studies currently available.
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HEMO study.9 Risk factors for infection identiﬁed among
patients with ESRD which are not related to renal
replacement therapy, and could apply at all stages of pre-
dialysis CKD, include: the causes and treatment of kidney
disease; comorbidities; reduced vaccine effectiveness;
and high levels of exposure to healthcare facilities.10
If there is an increased risk of infection incidence at
early stages of CKD, this would affect a large and growing
number of patients. Awareness and quantiﬁcation of this
risk could have beneﬁts for patient management, more
effective vaccination strategies and healthcare planning.
Narrative reviews have concluded that it is likely that
CKD in itself increases infection incidence, but reported
a lack of evidence.10–12 We are not aware of any relevant
systematic literature reviews of the effect of CKD on
infection incidence.
This review sought to assess systematically whether pre-
dialysis CKD is a risk factor for the incidence of acute,
community-acquired urinary tract infection (UTI), lower
respiratory tract infection (LRTI), central nervous
system (CNS) infection or sepsis, among community-
based adults in high-income countries.
METHODS
Data sources and searches
One reviewer (HIM) searched the MEDLINE and
EMBASE databases, and the Cochrane library, from
inception to 16 January 2014. The search strategies com-
bined text words and MeSH terms for three concepts:
acute community-acquired infection (sepsis, UTI, LRTI
or CNS infection), kidney disease and relative risk. We
used search terms to identify studies among adult
humans in high-income countries (according to the
World Bank classiﬁcation),13 and limited the search to
articles in English, French or German. The full strategies
are available in online supplementary tables S1–S3.
We searched the reference lists of all included studies
and any pertinent review articles to identify further eli-
gible studies.
Study selection
One reviewer (HIM) screened titles and abstracts,
reviewed the full text of identiﬁed studies and made
initial decisions on eligibility according to prespeciﬁed
inclusion criteria (see online supplementary table S4).
Any borderline cases were discussed between HIM, DN
and SLT. A second reviewer (DN) checked a sample of
100 abstracts, selected randomly after de-duplication of
records, and a κ statistic was calculated to describe
agreement in the selection of studies.
Eligible studies analysed the effect of predialysis kidney
disease on the relative risk of at least one of the four spe-
ciﬁed acute, community-acquired infections among
community-based adults in high-income countries. We
excluded study populations managed in secondary care
(unless for kidney disease), routinely treated with immu-
nosuppressants, or exclusively of pregnant women, as
these groups have a raised risk of infection, and the rela-
tionship of CKD to infection risk may be different among
these groups compared to that in the general adult popu-
lation in primary care. Ascertainment of CKD, as a silent
disease, and, to a certain extent, ascertainment of acute
community-acquired infections are dependent on high
levels of monitoring and good access to healthcare, so we
restricted our search to high-income countries. Chronic
infections such as tuberculosis were not included, as the
relationship between CKD and chronic infection is very
likely to differ from that between CKD and acute infec-
tions, which was our focus in this review.
To maximise the sensitivity of our search strategy, we
accepted a wide range of deﬁnitions of kidney disease,
including: medical diagnosis of kidney disease, reduced
estimated glomerular ﬁltration rate or creatinine clear-
ance, elevated creatinine, proteinuria, microalbuminuria
or macroalbuminuria and renal structural abnormalities.
We also accepted deﬁnitions which included some
patients with ESRD among the patients with CKD, but
excluded deﬁnitions which were exclusively patients
receiving renal replacement therapy.
Outcomes of interest were relative risk estimates of acute
community-acquired LRTIs, UTIs, CNS infections or sepsis.
We accepted outcomes describing incidence of severe
infections (such as hospitalisation with pneumonia).
We restricted our search to published studies which
were sufﬁciently large to include at least 30 participants
with and without kidney disease, to allow reasonable pre-
cision of the study estimate. Detailed eligibility criteria
are listed in online supplementary table S4.
Data extraction and quality assessment
Data were extracted from relevant studies using a prespe-
ciﬁed collection form. Study characteristics extracted
included study design, data source, any participant
exclusion criteria, number of participants, age, gender,
baseline renal function, deﬁnition of renal impairment
and deﬁnition of the outcome infection. An estimate of
relative risk (rate ratio, risk ratio or OR) with any mea-
sures taken to address confounding was extracted from
each eligible independent analysis in each study. Studies
with no CIs and for which the SE was not calculable
from the data presented were included in the review but
not considered for meta-analysis.
When multiple estimates were available from a study
but were not independent, a single estimate was identi-
ﬁed for potential meta-analysis by selecting the estimate
best adjusted for confounding, using the most recent
data, comparing the level of CKD most common in the
general population with no CKD.
Study quality was assessed using a prespeciﬁed tool
adapted from Higgins et al14 for observational studies.
Studies were assigned a high, low or uncertain risk of each
of the following: selection bias, non-differential measure-
ment error for exposure and outcome, information bias in
exposure and outcome, confounding and reverse caus-
ation. The minimum requirement for a low risk of bias
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from confounding was appropriate management of con-
founding by age, sex and diabetes. The speciﬁc criteria
used are detailed in online supplementary table S5.
Data synthesis and analysis
The relationship between CKD and UTIs was considered
likely to differ from that of CKD to other infections, due
to potential reverse causality. For example, repeat UTIs
may cause kidney disease, or structural kidney disease
may be identiﬁed through investigation of repeat UTIs.
Therefore, in all quantitative analysis, UTIs were ana-
lysed separately from other infections.
Estimates were examined for heterogeneity using
Cochran’s Q statistic and the I2 statistic as described by
Higgins et al.15 If I2 was less than 50% and Cochran’s Q
statistic p≥0.1, ﬁxed-effects meta-analysis was considered
for each of the two categories (UTI and other infections).
Funnel plots were constructed to look for publication
bias. All analysis was conducted using STATAV.12.0.
RESULTS
The database searches identiﬁed 10 380 citations, of
which 1204 were duplicates (ﬁgure 1). Both reviewers
had 100% agreement on which studies to extract for full-
text analysis from screening a random sample of 100
abstracts (Cohen’s Κ=1).
We identiﬁed 14 eligible studies, with varying study
characteristics (table 1). Four studies were case–control
studies,16–19 and 10 were cohort studies.20–29 Seven
studies investigated a range of risk factors for infec-
tion,16–19 21 28 29 two studies reported the effect of CKD
on infection as a confounder of the effect of interest24 25
and ﬁve studies investigated the effect of CKD on infec-
tion risk as their primary research question.5 20 22 26 27
Seven studies were based among the general popula-
tion.5 16 19 21 23 28 29 Other study populations included:
attendants at a specialist renal clinic,22 patients with
diabetes mellitus,25 patients admitted to hospital for
an acute cardiovascular event or an arterial revascularisa-
tion procedure,24 and the Navajo Nation—a population
which experiences 3–5 times higher rates of invasive
pneumococcal disease than the general US population.17
The population of the cohort studies in Calgary,
Canada comprised adults with a serum creatinine test
result available in their medical records.26 27 There is
some overlap in the study populations of these two cohort
studies: residents aged over 65 years with a serum creatin-
ine measurement between 1 July 2001 and 31 December
2001 and also between 1 July 2003 and 30 June 2004
would have been included in both studies for the period
from the second creatinine measurement until 31
December 2004.26 27
Figure 1 Flow chart of study
selection. *Common examples of
ineligible studies returned by the
database searches included:
studies in which renal failure and
infection were both outcomes,
studies in which renal failure and
infection were both exclusion
criteria, studies of acute renal
failure resulting from sepsis or
antibiotic use, studies of chronic
infections (e.g. hepatitis C, BK
viraemia, tuberculosis) following
organ transplantation, descriptive
studies of UTIs, descriptive
studies of CKD, studies of
predictors of prognosis among
patients with infections, and
review articles without any
original data.
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Table 1 Characteristics of eligible studies (n=14)
Case–control studies
Study Kidney disease Infection
Kidney disease
prevalence
Date Setting
Population Age
Percentage of
female Defined
ESRD
included Ascertained Type Defined Ascertained Cases Controls OR (95% CI)
Vinogradova et al16 1996–2005 UK General population
Any age Median
age band 45–
64 years
Cases 49.3%,
controls 49.1%
Chronic
renal
disease
Unclear Primary care medical
record diagnosis code
in previous 5 years
Pneumonia Medical diagnosis recorded in
primary care records
READ code in primary care
medical records
203/
17 172
(1.2%)
386/
71 299
(0.5%)
1.72 (1.3 to 2.07)1
Watt et al17 1999–2002 The
Navajo
Nation
USA
Navajo adults
≥18 years
Summary age and
sex n/r
Chronic
renal
failure
17 participants
receiving
dialysis
Medical record
abstraction
Invasive
pneumococcal
disease
Streptococcus pneumoniae isolated
from a normally sterile body fluid
during illness
Active laboratory surveillance
system2
20/118
(16.9%)
12/353
(3.4%)
2.6 (0.87 to 7.7)3
p=0.087
Loeb et al18 2002–2005 Ontario
and
Alberta
Canada
General population
≥65 years Mean
age: cases 79.1,
controls 74.4 years.
Cases 39.6%,
controls 68.5%
Renal
disease
Unclear Cases: hospital
interview. Controls:
telephone interview at
home
Pneumonia Consistent chest X-ray and ≥2 of:
chest pain, shortness of breath,
productive cough, temperature >38°
C, crackles on auscultation
Recruited patients attending
emergency departments
127/690
(18.4%)
38/82
(4.4%)
4.06 (1.98 to 8.35)4
p<0.001
Schnoor et al19 2002–2005 Germany General population
>18 years
Mean age:
cases 57,
controls 57.5 years
Cases 44.8%,
controls 54.7%
Chronic
renal
disease
Unclear Cases: reporting
physician.
Controls: self-reported
questionnaire
Pneumonia (1) Infiltrate on chest X-ray or (2)
temperature ≥38.3°C with any of:
cough, purulent sputum, positive
auscultation
Excluded if hospitalised within prior
4 weeks, or immunodeficient
Community-acquired pneumonia
network registry reports (primary
and secondary care)
49/1128
(4.3%)
27/1044
(2.6%)
1.7 (1.1 to 2.8)
(unadjusted)
p<0.05
Cohort studies
Study Kidney disease
Comparison
group Infection
Date
Setting
Follow-up
time
Population
Number
Age
Sex
Defined number
with kidney
disease ESRD Ascertained Defined Type Defined Ascertained Risk or rate ratio (95% CI)
Higgins22 1985 Oxford
UK
1 year
Patients attending a renal
unit with chronic renal
failure
n=211
17–77 years
Mean 50.5 years
Percentage of female n/r
Creatinine
≥250 µmol/L
Number n/r
Excluded Serum creatinine Creatinine
<250 µmol/L
UTI >105 organism/mL and ≥10
leucocytes/hpf in clean catch
urine specimen
Medical record review Creatinine µmol/L
<250 1
250–
500
1.55
>500 25
Dalrymple et al23 1989–2007 USA
Mean
11.5 years
General
community-dwelling
population6
n=5142
Baseline eGFR
<90 mL/min/1.73
m2 7
n=3863
Excluded Baseline cystatin C Baseline eGFR
≥90 mL/min/
1.73 m2 7
Pulmonary Hospital admission with a
principal discharge diagnosis
of the relevant infection
(ICD-9-CM codes)
Medical record review
following patient report
of hospital admission in
cohort study
eGFR mL/min/1.73m2
≥90 1
60–89 1.22 (0.99 to 1.54)8
45–59 1.27 (0.94 to 1.71)8
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Table 1 Continued
Cohort studies
Study Kidney disease
Comparison
group Infection
Date
Setting
Follow-up
time
Population
Number
Age
Sex
Defined number
with kidney
disease ESRD Ascertained Defined Type Defined Ascertained Risk or rate ratio (95% CI)
>65 years
Mean 72 years
61% female
15–44 1.81 (1.25 to 2.63)8
Genitourinary ≥90 1
60–89 1.08 (0.75 to 1.56)8
45–59 1.17 (0.67 to 2.05)8
15–44 2.63 (1.40 to 4.96)8
Bacteraemia and
sepsis
≥90 1
60–89 1.10 (0.77 to 1.58)8
45–59 1.55 (0.93 to 2.57)8
15–44 0.77 (0.29 to 2.03)8
Hackam et al24 1997–2002 Ontario
Canada
Mean
2.2 years
Patients with cardiovascular
disease
n=69 168
>65 years
Mean 74.1 years
44% female
Chronic renal
insufficiency
n=7169
Unclear Health record
databases9
No chronic renal
insufficiency
Sepsis Hospital admission with a
diagnosis of sepsis10
Health record
database11
1.47 (1.27 to 1.72)12
Karunajeewa et al25 1999–2000 Western
Australia
Mean
2.9 years
Patients with diabetes
n=496
>10 years
Mean 66.1 years13
46.2% female
Albuminuria;
serum urea;
serum creatinine
Unclear Baseline urinary
ACR,
serum urea,
serum creatinine
HR per 2.72-fold
increase in ACR
or serum urea
Urinary sepsis
and non-urinary
sepsis
Hospitalisation diagnosis
codes (principal diagnosis, or
principal or secondary
diagnosis)14
Health record
database15
Urinary sepsis (principal
code)
Ln
(ACR)
1.5 (1.1 to 1.9)16
p=0.004
Urinary sepsis (principal or
secondary code)
Ln
(ACR)
1.3 (1.1 to 1.6)17
p=0.005
Non-urinary sepsis (principal)
Ln
(ACR)
1.4 (1.1 to 1.9)16
Non-urinary sepsis (principal
or secondary code)
Ln
(urea)
4.6 (2.3 to 9.4)16
p<0.001
James et al26 2001–2004 Calgary
Canada
Mean
3.2 years
General population
n=25 675
>65 years
Mean by eGFR18
55.9% female
Baseline eGFR
<60 mL/min/1.73
m2 19
n=6941
Excluded Calgary Laboratory
Services records
Baseline eGFR
≥60 mL/min/
1.73 m2 19
Bloodstream
infection
Any pathogenic organism
isolated from ≥1 blood cultures
submitted from the community
or ≤2 days of hospital
admission
Calgary Laboratory
Services records
eGFR mL/min/1.73 m2
≥60 1
45–59 1.17 (0.92 to 1.49)20
30–44 1.60 (1.20 to 2.13)20
<30 2.95 (2.11 to 4.14)20
James et al27 2003–2006 Calgary
Canada
Median
2.5 years
General population
n=252 516
≥18 years
Mean by eGFR21
42.3% female
Time updated
eGFR <60 mL/
min/1.73 m2 22
n=35 948
Excluded Calgary Laboratory
Services records
eGFR 60–104 mL/
min/1.73 m2 22
Pneumonia ICD-10 code for pneumonia
any position in hospital
discharge report
Hospital discharge
reports
eGFR mL/min/1.73m2
18–54 years
60–
104
1
45–59 3.23 (2.40 to 4.36)23
30–44 9.67 (6.36 to 14.69)23
<30 15.04 (9.64 to 23.47)23
Age 55–64 years
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Table 1 Continued
Cohort studies
Study Kidney disease
Comparison
group Infection
Date
Setting
Follow-up
time
Population
Number
Age
Sex
Defined number
with kidney
disease ESRD Ascertained Defined Type Defined Ascertained Risk or rate ratio (95% CI)
60–
104
1
45–59 1.43 (1.11 to 1.84)23
30–44 1.94 (1.32 to 2.87)23
<30 5.50 (3.83 to 7.92)23
Age 65–74 years
60–
104
1
45–59 1.18 (0.99 to 1.40)23
30–44 2.24 (1.84 to 2.73)23
<30 3.23 (2.52 to 4.13)23
Age ≥75 years
60–
104
1
45–59 0.95 (0.85 to 1.05)23
30–44 1.03 (0.92 to 1.16)23
<30 1.79 (1.55 to 2.06)23
Wang et al28 2003–2011 USA
Mean
.7 years
General population sample
(weighted by age,
geography and ethnicity)24
n=30 239
≥45 years
69%>60 years
55% female
Baseline eGFR
<60 mL/min/1.73
m2 25
Unclear Baseline serum
creatinine
Baseline eGFR
≥60 mL/min/
1.73m2 25
Sepsis Among hospitalisations
attributed by participants to
serious infection, medical
record review26
Initially reported by
study participants,
confirmed with medical
record review
1.99 (1.73 to 2.29)27
Caljouw et al29 1998–2004 Leiden
The
Netherlands
Mean
2.6 years
General population
n=479
86–90 years
All aged 86 years at entry
67.2% female
Creatinine
clearance
<30 mL/min28
n=43
Unclear Baseline serum
creatinine
Creatinine
clearance ≥30 mL/
min28
UTI Diagnosed by treating
physician based on signs,
symptoms and urine analysis;
or death records29
Physician interview and
medical record review
Statistics Netherlands
for cause of death data
0.9 (0.5 to 1.7) (unadjusted)
p=0.794
Campbell et al21 2009–2010 England
UK
9 months
General population
n=43.9 million
6 months—64 years
Summary age and sex n/r
Chronic kidney
disease
n=182 000
Unclear Cases: consultant
microbiologist
report
Denominator:
primary care
population
estimate30
No pre-existing
conditions30
Pandemic
influenza A
(H1N1)
PCR test confirmation of
pandemic influenza A (H1N1)
from a hospital inpatient
Consultant
microbiologist report to
national surveillance
system
17.5 (13.4 to 22.9)31
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Table 1 Continued
Cohort studies
Study Kidney disease
Comparison
group Infection
Date
Setting
Follow-up
time
Population
Number
Age
Sex
Defined number
with kidney
disease ESRD Ascertained Defined Type Defined Ascertained Risk or rate ratio (95% CI)
USRDS 201020 2008 USA
1 year32
Medicare patients
66+ years
Chronic kidney
disease
Excluded Insurance
database
ICD-9-CM codes33
No CKD Pneumonia Principal cause of hospital
admission using hospital
insurance claim records
ICD-9-CM codes 480–
486
2.76 (unadjusted)
UTI ICD-9-CM codes34 3.15 (unadjusted)
Bacteraemia/
septicaemia
ICD-9-CM codes
038.0–038.9
3.90 (unadjusted)
1Controls matched to cases on age at index data (within 1 year), sex, general practice and calendar time. Estimate adjusted for smoking status, Townsend deprivation score, use of influenza vaccine in previous 12 months, use of pneumococcal vaccine in
previous 5 years, number of years of medical records data available in database, and comorbidities including: diabetes, chronic heart disease, chronic respiratory disease, asplenia, cerebrospinal shunt, chronic liver disease, sickle cell disease or coeliac
disease, cochlear implant, HIV/AIDS, immunosuppression, stroke or transient ischaemic attack, rheumatoid arthritis, Parkinson’s disease, multiple sclerosis, dementia, osteoporosis and any cancer.
2Center for American Indian Health surveillance system.
3Cases and controls matched by gender and age group. Adjusted for age, receipt of pneumococcal polysaccharide vaccine, congestive heart failure, alcohol use, body mass index and unemployment.
4Adjusted for age, non-English language spoken most at home, living in detached house, living alone, congestive heart failure, chronic obstructive pulmonary disease, dysphagia, functional status using Barthel Index, immunosuppressive medications,
nutritional score, tobacco use (lifetime history and secondhand smoke), alcohol consumption and history of regular exposure to gases, fumes or chemicals at home or at work.
5Approximate numbers, read from bar graph in publication. No CIs available.
6Cohort selected for the Cardiovascular Health Study. Exclusion criteria included: inability to provide informed consent or communicate with the interviewer, institutionalisation, being homebound, receipt of hospice care, treatment with radiation or
chemotherapy for cancer or plans to move out of the community within 3 years.
7Serum cystatin C measured by particle-enhanced immunonephelometric assay, and eGFR calculated using: eGFR=6.7×CysC−1.19.
8Adjusted for age, sex, race, tobacco use, body mass index, diabetes mellitus, coronary heart disease, stroke, heart failure, cancer, chronic obstructive pulmonary disease, serum albumin, C reactive protein, interleukin-6.
9Canadian Institute for Health Information Discharge Abstract database or Ontario Health Insurance Plan database.
10ICD-9 codes 003 1, 036 2 and 038 0–038 9.
11Canadian Institute for Health Information Discharge Abstract database.
12Adjusted for statins, age, sex, nature of index event, Charlson index, healthcare use, malignant disease, chemotherapy, neutropaenia, diabetes mellitus, oral steroids, antineoplastics, other immunosuppressants, history of aspiration, structural lung disease,
infection (respiratory, GI, skin/soft tissue or other), recent trauma, transplant recipient, heart failure, stroke, chronic liver disease, chronic obstructive pulmonary disease, alcoholism, dementia, Parkinson’s disease. Statin and non-statin users matched using
propensity scoring for the above factors.
13Mean age among the 460 participants without asymptomatic bacteriuria, 66.1 years (SD 11.0): mean age among the 36 participants with asymptomatic bacteriuria, 67.7 years (SD 10.5).
14ICD-9 or ICD-10 codes for urinary sepsis were those encoding UTI, cystitis, pyelonephritis, orchitis, epididymitis and prostatitis; codes for non-urinary sepsis were those for sepsis, septicaemia and/or abscess.
15Western Australia Data Linkage System.
16Adjusted for presence of asymptomatic bacteriuria.
17Adjusted for presence of asymptomatic bacteriuria and age.
18Mean age±SD by eGFR. ≥60: 74.4±6.5 years. 45–59: 77.5±7.2 years. 30–44: 79.3±7.4 years. <30: 78.6±7.4 years.
19eGFR calculated using abbreviated Modification of Diet in Renal Disease Study equation (omitting ethnicity) from single outpatient serum creatinine result.
20Adjusted for age, sex, diabetes mellitus, comorbidity score and care in a CKD clinic.
21Mean age±SD by eGFR. ≥105: 38.7±14.6. 60–104: 50.9±15.4. 45–59: 67.0±14.1. 30–44: 74.5±12.9. <30: 73.3±15.2.
22eGFR calculated using abbreviated Modification of Diet in Renal Disease Study equation (omitting ethnicity) from most recent outpatient serum creatinine result.
23Adjusted for age, sex, socioeconomic status, ethnicity, diabetes mellitus, Charlson comorbidity score.
24Cohort selected for the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Population weighted by age, ethnicity and geography according to local stroke incidence rates.
25eGFR calculated using the CKD-EPI equation.
26Medical record review confirming (1) serious infection as the major reason for admission and (2) ≥2 of heart rate >90 bpm, temperature >38.3°C or <36°C, tachypnoea >20 breaths/min or leucocytosis.
27Adjusted for age, sex, race, education, income, geographical region, alcohol use and smoking status.
28Creatinine clearance calculated from serum creatinine concentration and weight using the Cockcroft-Gault formula.
29Cause of death recorded as UTI (ICD-10 code N39.0)/.
30Department of Health-Health Protection Agency influenza vaccine uptake primary care monitoring system data.
31Adjusted for age.
32Smoothed estimate: models include data from the stated year and the 2 years preceding it, applying weights of 1, 1/4 and 1/8 with increasing distance in time.
33ICD-9-CM diagnosis codes recorded in insurance claims during the preceding year: 585.1-585.5 (chronic kidney disease stages 1–5); or 585.6 with no ESRD 2728 form or other indication of ESRD.
34Principal hospital admission ICD-9-CM codes: 590-590.9, 595-595.4, 597-597.89, 598, 599.0, 601-601.9, 604-604.9, 607.1-2, 608.0, 608.4, 616.1, 616.3-4 and 616.8.
ACR, albumin : creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; n/r, not reported; USRDS, US Renal Data
System; UTI, urinary tract infection.
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Deﬁnitions of kidney disease included medical diagno-
ses of chronic renal disease, elevated creatinine levels,
impaired creatinine clearance and structural abnormalities
of the kidney. Five studies excluded patients with ESRD,
and one speciﬁed the number included, but for the
remaining eight studies it was unclear how many of the
included patients received renal replacement therapy
(table 1).
Three studies recorded infections diagnosed in
primary care or outpatients,16 19 29 two recorded infec-
tions identiﬁed from a positive culture result,17 26 one
included infections diagnosed in the emergency depart-
ment,18 seven required hospital admission for infec-
tion5 21 23–25 27 28 and for one study the deﬁnition and
severity of infection was unclear.22
For two studies, the results extracted had no CI or SE
and these could not be calculated from the reported
data. From the remaining 12 studies, 17 independent
effect estimates with SEs were available for meta-analysis,
among which UTI was the outcome in three estimates.
For all infections, there was strong evidence of consider-
able heterogeneity (Cochran’s Q statistic p<0.001,
I2=96.5%). This persisted when estimates for UTIs were
excluded (p<0.001, I2=97.2%), when considering LRTIs
alone (p<0.001, I2=98.2%), when limited to cohort studies
(p<0.001, I2=97.3%), and when stratiﬁed by exclusion of
patients with ESRD (ESRD excluded, p<0.001, I2=88.9%:
ESRD not excluded p<0.001, I2=97.2%). Owing to this het-
erogeneity, meta-analysis was not performed.
All results are displayed in the Forest plot (ﬁgure 2).
Despite the quantitative heterogeneity, the results were
qualitatively similar: all estimates were compatible with a
positive association between kidney disease and infec-
tion. The four studies which compared different stages
of CKD found a graded association of increased risk of
infection with more severe CKD. All four of these
studies excluded patients with ESRD.22 23 26 27 One
study found that the effect of CKD on infection risk was
modiﬁed by age, with a declining effect of CKD on
infection risk as age increased.27 This effect was consist-
ent with the lower effect of CKD on UTI incidence
found among 86–90 year-olds (0.90, 95% CI 0.50 to
1.77) compared with an adult study population with a
mean age of 66 years (1.50, 95% CI 1.10 to 1.90).25 29
The funnel plot was sparsely populated, with widely
scattered effect estimates, and provides no clear evi-
dence for or against publication bias (see online supple-
mentary ﬁgure S1).
Study quality was variable. Relying on routine medical
diagnosis introduced a potential source of misclassiﬁca-
tion of kidney disease status for seven studies.5 16–19 21 24
There was variable adjustment for confounding, from
unadjusted crude estimates to estimates adjusted for a
range of comorbidities, demographic and socio-
economic factors. Six studies did not meet this review’s
minimal requirements.19 21 22 25 28 29 The summarised
results are displayed in table 2, and the full quality
assessment is in online supplementary table S5.
DISCUSSION
Our comprehensive search strategy identiﬁed 14 studies
describing an association between kidney disease and
acute community-acquired infection. Although between-
study heterogeneity precluded meta-analysis, all studies
were consistent with a positive direction of association.
Four studies which reported estimates on more than one
category of kidney disease found a graded association in
which risk of infection increased with greater severity of
CKD. These four studies excluded patients with ESRD,
and three were at low risk of bias in all categories of
quality assessment.22 23 26 27
To the best of our knowledge, this is the ﬁrst review to
address this research question systematically. We used a
sensitive search strategy, with a broad deﬁnition of
kidney disease, for a thorough and inclusive search. The
results are consistent with the conclusion of previous
narrative reviews: that an association between CKD and
infection incidence is likely, but that there is a paucity of
evidence.10–12
Heterogeneity between the studies precluded a
meta-analysis of results. Variable study designs and biases
may have contributed to the heterogeneity: for example,
the four case–control studies calculated ORs, which may
differ from equivalent rate ratios for common infec-
tions.16–19 Failure to control the confounding effects of
age, sex and diabetes would be likely to result in overesti-
mation of the effect of CKD on infection. Non-
differential misclassiﬁcation of kidney disease status in
studies which relied on routine medical diagnosis would
be expected to underestimate the effect of CKD on
infection risk. In general, the risk of ascertainment bias
from increased monitoring for infection among patients
with CKD is probably low, although one study assessed
risk factors for hospitalisation with inﬂuenza during an
inﬂuenza pandemic, in which context patients with
inﬂuenza-like symptoms may have been more likely to
be tested for inﬂuenza A(H1N1) if they also had CKD.21
The heterogeneity may reﬂect true differences in
effect size between the studies.
First, the studies considered a range of outcomes.
CKD may have a different effect on the incidence of dif-
ferent infections. For all but three studies, detection of
infection required either hospital attendance for the
infection or a positive blood culture. CKD may affect
severity of infection, as an alternative, or in addition to
any effect on infection incidence. CKD may also increase
the probability of hospital admission for management of
a moderately severe infection. Either would result in a
larger effect of CKD on the risk of severe infectious out-
comes (such as hospitalisation for sepsis) than on less
severe infections (such as community-diagnosed LRTI),
and could result in the graded association we observed,
with increasing hospitalisation for patients with more
severe stages of CKD.
Second, the studies included a variety of deﬁnitions of
kidney disease. For example, proteinuria (and renal loss
of complement) may represent a separate mechanism
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for risk of infection than uraemia. For the nine studies
which did not exclude patients with ESRD, it is unclear
to what extent the results reﬂect the effect of treatments
associated with dialysis, such as vascular or peritoneal
access for dialysis, on infection incidence.
Third, the association of CKD with infection may be
modiﬁed by age. James et al observed a weaker associ-
ation of CKD with hospitalisation for pneumonia as age
increased. They suggested that such an observation
could be explained by a lower baseline rate of hospital-
isation for pneumonia among younger adults, the
natural decline in renal function by age, and inaccuracy
in the estimation of renal function using the
Modiﬁcation of Diet in Renal Disease (MDRD) study
equation in older populations.27 As their study popula-
tion included only adults who had had a creatinine test
result, reasons for testing creatinine could also be rele-
vant confounders. As age increases, more comorbidities
accrue which require creatinine tests to guide therapy.
Hence, younger people who receive a creatinine test
may be at an unusually high risk for infections and CKD
due to the reasons associated with getting a creatinine
test. A real age-dependency of the CKD-infection associ-
ation would be consistent with the lower effect of CKD
on UTI incidence found among 86–90-year-olds (0.90,
95% CI 0.50 to 1.77) compared with an adult study
population with a mean age of 66 years (1.50, 95% CI
1.10 to 1.90). However, it may be that the study among
the older adults measured a less severe outcome, and
CKD may be associated with other factors that eventually
lead to hospitalisation for UTI.25 29
CKD was not a component of the primary study ques-
tion for nine of the 14 studies; thus, there is a risk that
this association may have been reported and published
only when CKD was found to be a risk factor for infec-
tion or an important confounder of another relation-
ship. This would result in selective reporting bias, with a
subsequent overestimation of the association of CKD
with infection risk. This bias would be expected to affect
smaller studies to a greater extent, and a funnel plot
might show an asymmetry of relative risk estimates about
the central pooled estimate among smaller studies. The
sparsely populated funnel plot (see online supplemen-
tary ﬁgure S1) provides no clear evidence for or against
selective reporting bias, but some evidence of selective
reporting bias comes from within the individual studies.
For example, the crude HR for the association of cre-
atinine clearance with UTI incidence is reported in
Figure 2 Forest plot of all estimates of the association of chronic kidney disease with infection (n=17) from all 14 studies
identified. The estimates from Higgins 1985 and USRDS 2010 did not include SEs. Dalrymple 2012: presented estimates
compare eGFR 45–59 with eGFR ≥90 mL/min/1.73m2; James 2009: presented estimates compare eGFR 45–59 with eGFR 60–
104 mL/min/1.73m2; James 2008: presented estimates compare eGFR 45–59 with eGFR≥60 mL/min/1.73m2. eGFR, estimated
glomerular filtration rate; ESRD, end-stage renal disease; USRDS, US Renal Data System; UTI, urinary tract infection.
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Caljouw et al29 (0.9, 95% CI 0.5 to 1.7), but as creatinine
clearance was not found to be signiﬁcant in the multi-
variable model, the adjusted association is not reported.
The overlap in the study populations of the two large
cohort studies based in Calgary, Canada could result in
more similar estimates than if the study populations
were independent.26 27 Outcomes in the two studies are
likely to be correlated with each other: hospitalisation
with pneumonia could cause a positive blood culture,
which would result in one infection being included as
an outcome in both studies. This is unlikely to have a
large effect, particularly in the qualitative assessment of
the combined evidence, as the potential overlap of
person-time is limited.
Although we excluded study populations routinely
treated with specialist medication (unless for kidney
disease), some study populations may have been at
higher risk of infection than the general population,
and this may have affected the relationship of CKD to
infection. For example, the cohort of patients admitted
for an acute cardiovascular event or an arterial revascu-
larisation procedure will have had a higher prevalence
of comorbidities (such as diabetes) than the general
population and excluded patients with severe comorbid-
ities who did not survive an acute cardiovascular event,
or who were not ﬁt enough to undergo the procedure.24
Each of the selected study populations limits the gener-
alisability of the individual study result, but the qualita-
tively similar ﬁndings across the variety of study
populations, and their qualitative consistency with the
studies based among the general population,5 16 19 21 23 28 29
support a positive association between CKD and infec-
tion risk in a variety of study populations.
A few large, high-quality studies which excluded
patients with ESRD have found a graded association
between predialysis CKD and risk of hospitalisation with
infection. All studies identiﬁed in this review were com-
patible with a positive association of CKD with increased
infection risk. There are little data available on the asso-
ciation of CKD with infection incidence using less severe
outcome measures than hospitalisation, and it is not pos-
sible in most studies to distinguish an effect on suscepti-
bility to infection from an effect on the severity of
infection.
The potential age-dependency of the relationship
between CKD and infection is intriguing and needs
further research. Also, there is currently no evidence on
the relationship between proteinuria and infection inci-
dence independent of the glomerular ﬁltration rate.
Future studies should identify infections in the commu-
nity in addition to hospitalisations for infection, charac-
terise the association of proteinuria adjusted for the
glomerular ﬁltration rate, explore the age-dependency
of the association and assess vaccine efﬁcacy among
older people with CKD.
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Table 2 Summary of risk of bias within studies (quality assessment tool adapted from Higgins et al14)
Selection bias:
control selection
Selection
bias:
participation
Selection bias:
loss to
follow-up
Non-differential
misclassification:
exposure
Information
bias: exposure
Non-differential
misclassification:
outcome
Information
bias: outcome Confounding
Reverse
causation
Case–control studies
Vinogradova et al16 NA
Watt et al17 NA
Loeb et al18 NA
Schnoor et al19 NA
Cohort studies
Higgins22 NA NA
Hackam et al24 NA NA
Dalrymple et al23 NA NA
Karunajeewa et al25 NA NA
James et al26 NA NA
James et al27 NA NA
Wang et al28 NA NA
Caljouw et al29 NA NA
Campbell et al21 NA NA
USRDS 201020 NA NA
Key to table 2.
Low risk of bias
Uncertain risk of bias
High risk of bias
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